{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-258115","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2023-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.505361+00:00","generated_at":"2026-06-09T21:55:05.260043+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aligos settles Janssen lawsuit; dismisses counterclaims, releases all parties","bullets":["Settlement agreement entered Oct 16, 2023 with Janssen Biotech resolving breach of contract and tortious interference claims.","Janssen dismisses action and releases Aligos, CEO Lawrence Blatt, and President Leonid Beigelman from all claims.","Aligos dismisses counterclaims for unfair competition and promissory fraud and releases Janssen.","No admission of liability or financial terms of settlement disclosed in the filing.","Litigation involved intellectual property ownership and claims against top executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-258115","json":"https://secwatch.observer/filing/0001193125-23-258115.json","markdown":"https://secwatch.observer/filing/0001193125-23-258115.md","text":"https://secwatch.observer/filing/0001193125-23-258115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/0001193125-23-258115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/d562095d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:55:05.260043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}